Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

Launched by UNIVERSITY HOSPITAL, LIMOGES · May 3, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring the best ways to screen people for viral infections like Hepatitis B, Hepatitis C, and HIV among individuals who use drugs, particularly those who might not access traditional healthcare settings. The goal is to set up special monthly screening days where a team of healthcare professionals, including doctors and nurses, work together to provide the necessary tests and support for each person involved.

To participate in this trial, you need to be an adult aged 18 or older and either use a non-traditional healthcare service or be referred by a healthcare professional. If you choose to take part, you can expect to receive a screening for these viral infections and personalized care based on your results. It's important to note that participation is entirely voluntary; if you don't want to join the study, that's perfectly okay. Your health and comfort are the top priority!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult 18 and over
• • Patient frequenting an unconventional structure "outside the walls" or referred by a professional in the care sector
• • Patient who agreed to participate to the research
• Exclusion Criteria:
• • Patient doesn't agree to participate to the research